[1]
Bryjak , A. 2014. Administration of liposomal doxorubicin in patients with metastatic breast cancer and significant concomitant cardiovascular conditions. OncoReview. 4, 4(16) (Dec. 2014), 148-154. DOI:https://doi.org/10.5604/20828691.1134303.